Pyridine derivatives as biologically active precursors; organics and selected coordination complexes

E Khan - ChemistrySelect, 2021 - Wiley Online Library
Pyridine (py) is an important heterocyclic compound and is an integral part of various natural
products. There are various medicines containing py ring system being available in the …

Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022

AK Singh, P Sonawane, A Kumar, H Singh… - ACS …, 2023 - ACS Publications
Serine/threonine-protein kinase B-Raf (BRAF; RAF= rapidly accelerated fibrosarcoma) plays
an important role in the mitogen-activated protein kinase (MAPK) signaling cascade …

[HTML][HTML] New potential agents for malignant melanoma treatment—most recent studies 2020–2022

P Kozyra, D Krasowska, M Pitucha - International Journal of Molecular …, 2022 - mdpi.com
Malignant melanoma (MM) is the most lethal skin cancer. Despite a 4% reduction in mortality
over the past few years, an increasing number of new diagnosed cases appear each year …

Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1, 3-diphenyl-1H-pyrazol-4-yl) pyridine sulfonamide derivatives

MS Abdel-Maksoud, RM Hassan, AAS El-Azzouny… - Bioorganic …, 2021 - Elsevier
A new series of N-(2-((4-(1, 3-diphenyl-1H-pyrazol-4-yl) pyridine sulfonamide derivatives
11a-o were designed and synthesized based on our previous works. The new series was …

Expanding the potential of pyridine scaffold for targeted therapy of cancer: biological activity, molecular insights, and structure-activity relationship

NVSS Aishwarya, GSP Matada, R Pal… - Journal of Molecular …, 2024 - Elsevier
Pyridine-based ring structures are widely employed in drug design due to their significant
impact on pharmacological activity, resulting in the development of various broad-spectrum …

Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Eáinhibitors

EMH Ali, MS Abdel-Maksoud, UM Ammar, KI Mersal… - Bioorganic …, 2021 - Elsevier
Abstract BRAF V600E mutation has been detected in various malignant tumours.
Develo** of potent BRAF V600E inhibitors is considered a leading step in the way to cure …

An updated literature on BRAF inhibitors (2018–2023)

L Maji, G Teli, NM Raghavendra, S Sengupta, R Pal… - Molecular Diversity, 2024 - Springer
BRAF is the most common serine-threonine protein kinase and regulates signal transduction
from RAS to MEK inside the cell. The BRAF is a highly active isoform of RAF kinase. BRAF …

Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents

VJ Singh, B Sharma, PA Chawla - Bioorganic Chemistry, 2021 - Elsevier
The mitogen activated protein kinase (MAPK) belongs to group of kinase that links the
extracellular stimuli to intracellular response. The MAPK signalling pathway (RAS-RAF-MEK …

Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer

J Chavda, H Bhatt - European Journal of Medicinal Chemistry, 2020 - Elsevier
Cancer is one of the major public catastrophes worldwide and as per WHO, cancer is the
leading cause of death universally after CVS disorders accounting for 9.6 million deaths in …

Anticancer and anti-inflammatory effects of novel ethyl pyrazole derivatives having sulfonamide terminal moiety

MS Abdel-Maksoud, SA Nasser, RM Hassan… - Bioorganic …, 2024 - Elsevier
In the present work, a new series of ethyl pyrazole-containing compounds with side
sulphonamide moiety was designed and synthesized. The new derivatives were divided into …